Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Fumonisin Inhibition of Ceramide Synthase: A Possible Risk Factor for Human Neural Tube Defects

  • Chapter
Sphingolipid Biology

Summary

Fumonisins are carcinogenic mycotoxins that cause farm animal diseases. They commonly contaminate maize and are suspected, but not proven, to cause human disease. Their mode of action involves inhibition of the enzyme (ceramide synthase) that controls the formation of sphingolipids, important regulators of pathways involved in cell death and survival. Sphingolipids are needed for the proper function of receptors associated with lipid rafts (for example, the high affinity folate-binding protein). Fumonisin disruption of folate transport interferes with neural tube closure in animal models in vitro, and this effect is reduced by folate supplementation. In vivo studies in the LMBc mouse strain have shown that maternal fumonisin administration during pregnancy causes a dose-related increase in the frequency of neural tube defects (NTDs) in the embryos. Co-exposing the dams to folate or ganglioside GM1 is protective, suggesting that fumonisin alters sphingolipid-dependent lipid raft function. In addition, altered expression of cytokines, inducible nitric oxide synthase, elevated levels of sphinganine and sphinganine 1-phosphate and several genes involved in redox homeostasis are observed in affected embryos. NTDs are the second most common birth defect in humans. The etiology of human NTDs is complex. Increased risk has been associated with genetic predisposition, dietary exposure to environmental contaminants, and reduced intake of folate and other vitamins/nutrients. Human clinical and epidemiological studies show folate supplementation reduces the risk for NTDs. While there is no direct evidence for fumonisin as a cause of NTD in humans, the incidence of NTD is higher where maize consumption is high, and both fumonisin exposure and folate deficient diets are likely. Thus, it has been hypothesized that fumonisin inhibition of ceramide synthase is a risk factor for NTDs in humans with folate deficient diets who consume large quantities of low quality maize.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

5. References

  • Bolger M, Coker RD, Dinovi M, Gaylor D, Gelderblom MO, Paster N, Riley RT, Shephard G, and Speijers JA (2001) Fumonisins. In: Safety evaluation of certain mycotoxins in food. Food and Agriculture Organization of the United Nations, paper 74. World Health Organization Food Additives, Series 47, 103–279.

    Google Scholar 

  • Brown DA and London E (1998) Functions of lipid rafts in biological membranes. Anna Rev Cell Dev Biol, 14, 111–136.

    Article  CAS  Google Scholar 

  • Campbell LR, Dayton DH and Sohal GS (1986) Neural tube defects: A review of human and animal studies on the etiology and neural tube defects. Teratology, 34, 171–187.

    Article  PubMed  CAS  Google Scholar 

  • CDC (2000) Neural tube defect surveillance and folic acid intervention — Texas-Mexico border, 1993–1998. Morbidity and Mortality Weekly Report, 49(1), 1–4.

    Google Scholar 

  • Cifuentes G (2002) Perfil epidemiologico de las anomalias del tubo neural en Guatemala, durante el año 2000. in Graduation Thesis of the School of Medicine of Universidad San Carlos de Guatemala.

    Google Scholar 

  • Collins TFX, Sprando RL, Black TN, Olejnik N, Eppley RM, Shackelford ME, Howard PC, Rorie JI, Bryant M, Ruggles DI (2005) Effects of aminopentol on in utero development in rats. Food Chem Toxicol, in press.

    Google Scholar 

  • Constable PD, Riley RT, Waggoner AL, Hsiao S-H, Foreman JH, Tumbleson ME and. Haschek WM (2005) Serum sphingosine-1-phosphate and sphinganine-1-phosphate are elevated in horses exposed to Fumonisin B1. in AOAC International Midwest Section Final Program, pp. 63–64.

    Google Scholar 

  • Czeizel AE and Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptual vitamin supplementation. N Engl J Med, 327, 1832–1835.

    Article  PubMed  CAS  Google Scholar 

  • da Costa M, Sequeira JM, Rothenberg SP, Weedon J. (2003) Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res Part A Clin Mol Teratol, 67, 837–847.

    Article  PubMed  CAS  Google Scholar 

  • Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC (2005) Human neural tube defects: Developmental biology, epidemiology, and genetics. Neurotoxicology and Teratology, 27, 515–524.

    Article  PubMed  CAS  Google Scholar 

  • Enongene EN, Sharma RP, Bhandari N, Meredith FI, Voss KA and Riley RT (2002) Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Tox Sci, 67, 173–181.

    Article  CAS  Google Scholar 

  • Feuchtbaum LB, Currier RJ, Riggle S, Robertson M, Lorey FW, Cunningham GC (1999) Neural tube defect prevalence in California (1990–1994): Eliciting patterns by type of defect and maternal race/ethnicity. Genetic Testing, 3(3), 265–272.

    Article  PubMed  CAS  Google Scholar 

  • Figueroa Cardenas JD, Acero Godinez MG, Vasco Mendez NL, Lozano Guzman A, Flores Acosta LM, Gonzalez-Hernandez J (2001) Fortification and evaluation of the nixtamal tortillas. Arch Latinoam Nutr, 51, 293–302.

    PubMed  CAS  Google Scholar 

  • Flynn TJ, Pritchard D, Bradlaw J, Eppley R and Page S (1996) In vivo embryo-toxicity of fumonisin B1 evaluated with cultured postimplantation staged rat embryos. In vitro Toxicology, 9, 271–279.

    CAS  Google Scholar 

  • Flynn TJ, Stack ME, Troy AL and Chirtel SJ (1997) Assessment of the embryo-toxic potential of the total hydrolysis product of fumonisin B1 using cultured organogenesis-staged rat embryos. Food Chem Toxicol, 35, 1135–1141.

    Article  PubMed  CAS  Google Scholar 

  • Gelderblom WCA, Kriek NPJ, Marasas WFO, and Thiel PG (1991) Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis, 12, 1247–1251.

    Article  PubMed  CAS  Google Scholar 

  • Gelineau-van Waes J, Starr L, Maddox JR, Aleman F, Voss KA, Wilberding J and Riley RT (2005) Maternal fumonisin exposure and risk for neural tube defects: Disruption of sphingolipid metabolism and folate transport in an in vivo mouse model. Birth Defects Research (A), 73, 487–497.

    Article  CAS  Google Scholar 

  • Gelineau-van Waes J, Maddox J, Starr L, Wilberding J, Bauer L, Voss K, and Riley R (2006) Maternal fumonisin exposure and neural tube defects: Mechanisms in a mouse model. Tox Sci (Suppl. The Toxicologist), 85(S1), accepted.

    Google Scholar 

  • Green NS (2002) Folic acid supplementation and prevention of birth defects. J Nutr, 132, 2356S–2360S.

    PubMed  CAS  Google Scholar 

  • Hendricks K (1999) Fumonisins and neural tube defects in South Texas. Epidemiol, 10, 198–200.

    Article  CAS  Google Scholar 

  • Hansen, DK, Streck, RD and Antony, AC (2003) Antisense modulation of the coding or regulatory sequence of the folate receptor (folate binding protein-1) in mouse embryos leads to neural tube defects. Birth Defects Res Part A Clin. Mol Teratol, 67, 475–487.

    Article  PubMed  CAS  Google Scholar 

  • Humpf H-U, and Voss KA (2004) Effects of food processing on the chemical structure and toxicity of fumonisin mycotoxins. Mol Nutr Food Res, 48, 255–269.

    Article  PubMed  CAS  Google Scholar 

  • IARC (2002) (International Agency for Research on Cancer). Fumonisin B1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Traditional Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC, 82, 301–366.

    Google Scholar 

  • IPCS (International Programme on Chemical Safety). (2000) Fumonisin B1, Environmental Health Criteria 219. World Health Organization, Geneva, 150 pp

    Google Scholar 

  • Kromberg JG and Jenkins T. (1982) Common birth defects in South African Blacks. S Afr Med J, 62(17), 599–602.

    PubMed  CAS  Google Scholar 

  • Lian Z-H, Yang H-Y and Li Z (1987) Neural tube defects in Beijing-Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics. J Epidemiol Community Health, 41, 259–262.

    Article  PubMed  CAS  Google Scholar 

  • Luhrs CA and Slomiany BL (1989) A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail. J Biol Chem, 264, 21446–21449.

    PubMed  CAS  Google Scholar 

  • Marasas WFO, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, Missmer, SA, Cabrera Valverde J, Torres OL, Gelderblom W, Alle-good J, Martínez de Figueroa AC, Maddox J, Miller JD, Starr L, Sullards MC, Roman Trigo AV, Voss KA, Wang E, Merrill AH, Jr (2004) Fumonisins disrupt sphingolipid metabolism, folate transport and development of neural crest cells in embryo culture and in vivo: A risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize? J Nutr, 134, 711–716.

    PubMed  CAS  Google Scholar 

  • March of Dimes Perinatal Data Center (2001) Maternal, Infant, and Child Health in the United States.

    Google Scholar 

  • Melnick M and Marazita ML (1998). Neural tube defects, methylenetetrahydrofolate reductase mutation, and north/south dietary differences in China. J Craniofac Genet Dev Biol, 18, 233–235.

    PubMed  CAS  Google Scholar 

  • Meredith F I, Torres O R, Saenz de Tejada S, Riley R T and Merrill A H Jr (1999) Fumonisin B1 and hydrolyzed fumonisin B1 levels in nixtamalized maize (Zea mays L.) and tortillas from two different geographical locations in Guatemala. J Food Prot, 62, 1218–1222.

    PubMed  CAS  Google Scholar 

  • Merrill AH Jr, Sullards MC, Wang E, Voss KA and Riley RT (2001) Sphingolipid metabolism:Roles in signal transduction and disruption by fumonisins. Environ Health Perspect, 109, 283–289.

    Article  PubMed  CAS  Google Scholar 

  • Merrill AH Jr. (2002) De novo sphingolipid biosynthesis: A necessary, but dangerous, pathway. J Biol Chem, 277, 25843–25846.

    Article  PubMed  CAS  Google Scholar 

  • Mitchell LE (2005) Epidemiology of neural tube defects. American Journal of Medical Genetics Part C, 135C, 88–94.

    Article  Google Scholar 

  • Moore CA, Li S, Gu H, Berry RJ, Mulinare J and Erickson JD (1997) Elevated rates of severe neural tube defects in a high-prevalence area in Northern China. Amer J Med Genetics, 73, 113–118.

    Article  CAS  Google Scholar 

  • MRC (1991) MRC Vitamin Study Research Group Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet II, 131–137.

    Google Scholar 

  • NTP (2001) (National Toxicology Program Technical Report). (2002) Toxicology and Carcinogenesis Studies of Fumonisin B1 in F344/N rats and B6C3F1 mice. Publication no. 99-3955, NIH, Washington, DC

    Google Scholar 

  • Ncayiyana DJ (1986) Neural tube defects among rural blacks in a Transkei district. S A Med J, 69, 618–620.

    CAS  Google Scholar 

  • Palencia E, Torres O, Hagler W, Meredith FI, Williams L D, and Riley RT (2003) Total fumonisins are reduced in tortillas using the traditional nixtamalization method of Mayan communities. J Nutr, 133, 3200–3203.

    PubMed  CAS  Google Scholar 

  • Piva A, Casadei G, Pagliuca G, Cabassi E, Galvano F, Solfrizzo M, Riley RT and Diaz DE (2005) Inability of activated carbon to prevent the toxicity of culture material containing fumonisin B1 when fed to weaned piglets. J Animal Sci, 83, 1939–1947

    CAS  Google Scholar 

  • Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, Lacey SW, Anderson RG and Finnell RH (1999) Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nature Genetics, 23, 228–232.

    Article  PubMed  CAS  Google Scholar 

  • Rheeder J P, Marasas W F O, Thiel P G, Sydenham E W, Shephard G S and Van Schalkwyk D J (1992) Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathology, 82, 353–357.

    Article  Google Scholar 

  • Riley RT, Enongene E, Voss KA, Norred WP, Meredith FI, Sharma RP, Spitsbergen J, Williams DE, Carlson DB and Merrill AH Jr (2001) Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect, 109, 301–308.

    Article  PubMed  CAS  Google Scholar 

  • Riley RT, Showker JL, Voss KA (2005a) Time-and dose-dependent changes in sphingoid base 1 phosphates in tissues from rats fed diets containing fumonisins. Tox Sci (Suppl. The Toxicologist), 84(S1), 284–285.

    Google Scholar 

  • Riley RT, Torres OA, Palencia E, Lopez de Pratdesaba L, Glenn AE, O’Donnell K and Fuentes M. (2005b) Fumonisins in highland and lowland maize in Guatemala and a preliminary exposure estimate. AOAC International Midwest Section Final Program, pp. 34–35.

    Google Scholar 

  • Rothenberg SP, Da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, and Quadros EV (2004) Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. Obstet Gynecol Surv, 59, 410–411.

    Article  Google Scholar 

  • Sadler TW, Merrill AH, Jr, Stevens VL, Sullards MC, Wang E and Wang P (2002) Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology, 66, 169–176.

    Article  PubMed  CAS  Google Scholar 

  • Shaw GM, Schaffer D, Velie E, Morland KM and Harris JA (1995) Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiol, 6, 219–226.

    Article  CAS  Google Scholar 

  • Shephard GS (2004). Mycotoxins worldwide: Current issues in Africa. In Barug D, Van Egmond, H.P., López Garciá, R., Van Osenbruggen, W.A. & Visconti, A. Meeting the mycotoxin menace. Wageningen Academic Publishers, the Netherlands, pp. 81–88.

    Google Scholar 

  • Stevens VL and Tang J (1997) Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem, 272, 18020–18025.

    Article  PubMed  CAS  Google Scholar 

  • Venter PA, Christianson AL, Hutamo CM, Makhura MP and Gericke GS (1995) Congenital anomalies in rural black South African neonates-a silent epidemic? S A Med J, 83, 15–20.

    Google Scholar 

  • Voss KA, Riley RT, and Gelineau-van Waes J (2005a) Trends in fumonisin research: Recent studies on the developmental effects of fumonisins and Fusarium verticillioides. Mycotoxins, 55, 91–100.

    Article  CAS  Google Scholar 

  • Voss KA, Gelineau van-Waes JB, Riley RT, Burns TD, Bacon CW. (2005b) Developmental toxicity of diets containing fumonisin B1 to LM/Bc and CD1 mice: a comparative study. Tox Sci (Suppl. The Toxicologist), 84(S1), 1396.

    Google Scholar 

  • Wang E, Norred WP, Bacon CW, Riley RT, and Merrill AH Jr (1991) Inhibition of sphingolipid biosynthesis by fumonisins: Implications for diseases associated with Fusarium moniliforme. J Biol Chem, 266, 14486–14490.

    PubMed  CAS  Google Scholar 

  • Wang E, Riley RT, Meredith FI and Merrill AH Jr (1999) Time course, dose-dependence, and reversibility of increases in urinary sphinganine and sphingosine in animals fed defined diets containing fumonisin B1: characteristics of urinary biomarkers for exposure to fumonisins. J Nutr, 129, 214–220.

    PubMed  CAS  Google Scholar 

  • Werler MM, Sharpio S and Mitchell AA (1993) Periconceptual folic acid exposure and risk of occurrent neural tube defects. JAMA, 269, 1257–1261.

    Article  PubMed  CAS  Google Scholar 

  • WHO (2001) World Health Organization. Evaluation of Certain Mycotoxins in Food. Fifty-sixth Report of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Technical Report, 906, 16–27.

    Google Scholar 

  • Xiao KZ, Zhang ZY, Su YM, Liu FQ, Yan ZZ, Jiang ZQ, Zhou SF, He WG, Wang BY, Jiang HP, (1990). Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese Birth Defects Monitoring Program. Int J Epidemiol 19, 978–982.

    Article  PubMed  CAS  Google Scholar 

  • Yoshizawa T, Yamashita A and Luo Y (1994) Fumonisin occurrence in corn from high-and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol, 60, 1626–1629.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Toxicology and Mycotoxin Research Unit, United States Department of Agriculture-Agricultural Research Service, PO Box 5677, Athens, Georgia, 30604, USA

    Ronald T. Riley & Kenneth A. Voss

  2. Duke Center for Human Genetics, School of Medicine, Duke University, Durham, North Carolina, 27710, USA

    Marcy Speer

  3. Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia, USA

    Victoria L. Stevens

  4. Department of Genetics, Cell Biology & Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, 68198-5455, USA

    Janee Gelineau-van Waes

Authors
  1. Ronald T. Riley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth A. Voss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcy Speer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Victoria L. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Janee Gelineau-van Waes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Brain Science Institute, The Institute of Physical and Chemical Research (Riken), 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan

    Yoshio Hirabayashi

  2. Department of Biomembrane and Biofunctional Chemistry, Faculty of Advanced Life Science and Graduate School of Life Science, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, 060-0812, Japan

    Yasuyuki Igarashi

  3. School of Biology and the Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, 30332, USA

    Alfred H. Merrill Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Riley, R.T., Voss, K.A., Speer, M., Stevens, V.L., Gelineau-van Waes, J. (2006). Fumonisin Inhibition of Ceramide Synthase: A Possible Risk Factor for Human Neural Tube Defects. In: Hirabayashi, Y., Igarashi, Y., Merrill, A.H. (eds) Sphingolipid Biology. Springer, Tokyo. https://doi.org/10.1007/4-431-34200-1_28

Download citation

Publish with us

Policies and ethics

Search

Navigation